Education
About Us
Working with TipRanks
Follow Us
Jagsonpal Pharmaceuticals Ltd. (IN:JAGSNPHARM)
:JAGSNPHARM
JAGSNPHARM Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹140.00 - ₹328.02
Previous CloseN/A
Volume94.85K
Average Volume (3M)59.51K
Market Cap
₹16.93B
Enterprise Value₹10.62B
Total Cash (Recent Filing)₹1.29B
Total Debt (Recent Filing)₹92.39M
Price to Earnings (P/E)27.8
Beta1.19
Next Earnings
Nov 18, 2025EPS EstimateN/A
Next Dividend Ex-Date
Sep 12, 2025Dividend Yield0.79%
Share Statistics
EPS (TTM)1.62
Shares Outstanding66,526,480
10 Day Avg. Volume122,885
30 Day Avg. Volume59,508
Financial Highlights & Ratios
PEG Ratio-11.17
Price to Book (P/B)6.09
Price to Sales (P/S)5.44
P/FCF Ratio26.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
JAGSNPHARM FAQ
What was Jagsonpal Pharmaceuticals Ltd.’s price range in the past 12 months?
Jagsonpal Pharmaceuticals Ltd. lowest stock price was ₹140.00 and its highest was ₹328.02 in the past 12 months.
What is Jagsonpal Pharmaceuticals Ltd.’s market cap?
Jagsonpal Pharmaceuticals Ltd.’s market cap is ₹16.93B.
When is Jagsonpal Pharmaceuticals Ltd.’s upcoming earnings report date?
Jagsonpal Pharmaceuticals Ltd.’s upcoming earnings report date is Nov 18, 2025 which is in 100 days.
How were Jagsonpal Pharmaceuticals Ltd.’s earnings last quarter?
Jagsonpal Pharmaceuticals Ltd. released its earnings results on Jul 26, 2025. The company reported ₹1.623 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.623.
Is Jagsonpal Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts Jagsonpal Pharmaceuticals Ltd.’s price is currently Overvalued.
Does Jagsonpal Pharmaceuticals Ltd. pay dividends?
Jagsonpal Pharmaceuticals Ltd. pays a Annually dividend of ₹2.5 which represents an annual dividend yield of 0.79%. See more information on Jagsonpal Pharmaceuticals Ltd. dividends here
What is Jagsonpal Pharmaceuticals Ltd.’s EPS estimate?
Jagsonpal Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jagsonpal Pharmaceuticals Ltd. have?
Jagsonpal Pharmaceuticals Ltd. has 66,526,480 shares outstanding.
What happened to Jagsonpal Pharmaceuticals Ltd.’s price movement after its last earnings report?
Jagsonpal Pharmaceuticals Ltd. reported an EPS of ₹1.623 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.439%.
Which hedge fund is a major shareholder of Jagsonpal Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in IN:JAGSNPHARM
Company Description
Jagsonpal Pharmaceuticals Ltd.
Jagsonpal Pharmaceuticals Limited develops and manufactures bulk drugs and pharmaceutical formulations in the areas of women health, pain and analgesics, and general medicine. It offers general medicines, such as allergy management, immunity and cell protection, gut and mind management, anti-infectives, and dentist and ENT range products; and women's healthcare products, including pregnancy care, and dysfunctional uterine bleeding complications and management products. The company also provides pain and analgesics products in the areas of pain management, and bone and joint care. It offers drugs in the form of tablets, capsules, and syrups. The company was founded in 1964 and is based in New Delhi, India. Jagsonpal Pharmaceuticals Limited is a subsidiary of Aresko Progressive Private Limited.
Technical Analysis
Bajaj Healthcare Ltd
―
Bliss Gvs Pharma Limited
―
Hester Biosciences Limited
―
Lincoln Pharmaceuticals Ltd
―
Themis Medicare Limited
―